Effects of protein restriction on insulin-like growth factor (IGF)-1 in men with prostate cancer: results from a randomized clinical trial
María Lastra Cagigas(The University of Sydney), Luigi Fontana(The University of Sydney), Andrius Masedunskas(UNSW Sydney), Francesco Spelta, Giovanni Fiorito(Istituto Giannina Gaslini), Gayathiri Rajakumar(The University of Sydney), Robert S. Figenshau(Washington University in St. Louis), Valeria Tosti(Washington University in St. Louis), Nicola Veronese(University of Palermo), Beatrice Bertozzi(Washington University in St. Louis), Arnold Bullock(Washington University in St. Louis), Edda Cava(Carlo Forlanini Hospital), Gerald L. Andriole(Institut thématique Génétique, génomique et bioinformatique), Tiana Pelaia(The University of Sydney)
Cited by 6
Related Papers
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controls
|World Psychiatry|2017|1.7k
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
|The Lancet Psychiatry|2019|1.5k
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
|Nature Genetics|2007|1.1k
Multiple loci identified in a genome-wide association study of prostate cancer
|Nature Genetics|2008|907